Carlson Capital’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-293,460
| Closed | -$590K | – | 34 |
|
|
2024
Q3 | $590K | Hold |
293,460
| – | – | 0.36% | 4 |
|
|
2024
Q2 | $487K | Buy |
293,460
+99,500
| +51% | +$261K | 0.08% | 88 |
|
|
2024
Q1 | $1.17M | Hold |
193,960
| – | – | 0.1% | 100 |
|
|
2023
Q4 | $1.36M | Sell |
193,960
-1,040
| -0.5% | -$8.08K | 0.11% | 101 |
|
|
2023
Q3 | $1.71M | Buy |
195,000
+143,800
| +281% | +$1.35M | 0.13% | 109 |
|
|
2023
Q2 | $602K | Hold |
51,200
| – | – | 0.05% | 106 |
|
|
2023
Q1 | $877K | Buy |
51,200
+1,520
| +3% | +$32.9K | 0.08% | 101 |
|
|
2022
Q4 | $1.3M | Buy |
49,680
+38,680
| +352% | +$1.84M | 0.1% | 100 |
|
|
2022
Q3 | $1.12M | Sell |
11,000
-1,000
| -8% | -$135K | 0.08% | 107 |
|
|
2022
Q2 | $1.7M | Sell |
12,000
-400
| -3% | -$55.8K | 0.12% | 104 |
|
|
2022
Q1 | $1.96M | Buy |
12,400
+3,680
| +42% | +$594K | 0.13% | 125 |
|
|
2021
Q4 | $1.93M | Sell |
8,720
-388
| -4% | -$75.1K | 0.11% | 118 |
|
|
2021
Q3 | $1.76M | Buy |
9,108
+508
| +6% | +$108K | 0.09% | 139 |
|
|
2021
Q2 | $2.07M | Buy |
8,600
+1,800
| +26% | +$494K | 0.1% | 125 |
|
|
2021
Q1 | $2.31M | Buy |
+6,800
| New | +$2.77M | 0.09% | 142 |
|
Other funds holding TFFP
Carlson Capital's TFFP Position: Q4 2024 in Review
Carlson Capital sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2024, closing a stake of 293,460 shares — an estimated $590K sold.
Carlson Capital first reported a position in TFFP in Q1 2021 and held it in 15 quarters. The position peaked at $2.31M in Q1 2021. 4 funds tracked by Wall St. Rank hold TFFP as of Q4 2024.
- Carlson Capital reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Carlson Capital sold 293,460 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $590K.
- Carlson Capital first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 15 quarters.
- Carlson Capital's TFF Pharmaceuticals, Inc. Common Stock position peaked at $2.31M in Q1 2021.
- 4 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2024.
Based on Carlson Capital's 13F filing for Q4 2024, filed 5 Feb 2025.